Jiangxi Jemincare Group

Jiangxi Jemincare Group is a leading Chinese pharmaceutical company founded in 1999, headquartered in Nanchang. The company operates across the entire value chain, including R&D, manufacturing, and commercialization, with a strong focus on nephrology, oncology, cardiovascular, and anti-infection therapeutic areas. Jemincare has established a global R&D presence with centers in Shanghai and the United States, focusing on both innovative small molecules and biologics. They are well-known for their traditional Chinese medicine (TCM) heritage but have aggressively pivoted towards modern innovative drug discovery through high-profile out-licensing deals with global partners like Genentech and Orion. The group maintains a robust commercial network in China and is consistently ranked among the top pharmaceutical enterprises in the country.